Bhutan

Novo Nordisk: Differential Pricing on Insulin

Among the targets for UN Millennium Development Goal 8 is a call for partnerships with pharmaceutical companies to provide access to affordable essential drugs in developing countries. Since 2001, Novo Nordisk has offered human insulin to the public health systems in Least Developed Countries (LDCs) at prices which do not to exceed 20% of the average price in Europe, Japan and North America. In 2009, Novo Nordisk offered this pricing scheme to all 49 LDCs, of which 36 used it to buy insulin at or below this price, compared to 32 in 2008.

Leprosy Elimination

Novartis is providing free treatment for leprosy patients worldwide through its multi-drug therapy.

JPMA: Strengthening Quality Control in Asia

The Japan Pharmaceutical Manufacturers Association (JPMA) helps developing countries in Asia to establish efficient pharmaceutical distribution and quality control systems, via the following activities: Training in Japan: Since 1989, the JPMA has worked with the World Health Organization to provide annual Quality Control training courses in Japan for Asian government quality control personnel. JPMA provides practical training in medicines quality control at research laboratories and manufacturing plants, with the help of its member companies.

HPV Vaccine & Cervical Cancer

Cervical cancer is the second most common cancer in women worldwide, with about 500,000 new cases and 250,000 deaths occurring each year. Almost 80% of cases occur in low-income countries, where cervical cancer is the number one cause of cancer in women. Virtually all cervical cancer cases (99%) are linked to genital infection with human papillomavirus (HPV), a family of virus types which also causes genital warts and other forms of cancer.

Global Pharma Health Fund

The Global Pharma Health Fund e.V. (GPHF) is a charitable organization initiated and funded exclusively by donations from Merck KGaA, Darmstadt Germany. In 2007, it took over the work of the former German Pharma Health Fund, which was set up in 1985. The organization aims to improve health care in the context of development assistance, in particular the use of the GPHF-Minilab in the fight against counterfeit drugs.

World Health Organization WHO

World Bank

The World Bank is a vital source of financial and technical assistance to developing countries around the world.

Program for Appropriate Technology in Health PATH

International Diabetes Federation

The International Diabetes Federation (IDF) is a worldwide alliance of over 200 diabetes associations in more than 160 countries, who have come together to enhance the lives of people with diabetes everywhere.

Global Pharma Health Fund

The Global Pharma Health Fund (GPHF) is a charitable organization initiated and funded exclusively by donations from Merck Darmstadt Germany.

Within international development assistance initiatives, the GPHF aims to improve health care and medicines supply, the work currently supporting the fight against counterfeit and substandard quality medicines proliferation using GPHF-Minilab® test kits.

Pages